enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Cluster headache - Wikipedia

   en.wikipedia.org/wiki/Cluster_headache

   Treatment: Oxygen therapy, triptans [2] [4] ... Cluster headache is a neurological disorder characterized by recurrent severe headaches on one side of the head, ...

3. Demand valve oxygen therapy - Wikipedia

   en.wikipedia.org/wiki/Demand_Valve_Oxygen_Therapy

   DVOT is commonly used to treat conditions such as cluster headache, which affects up to four in 1000 people (0.4%), [1] [2] [3] and is a recommended first aid procedure for several diving disorders. [ 4 ] [ 5 ] It is also a recommended prophylactic for decompression sickness in the event of minor omitted decompression without symptoms.

4. Trigeminal autonomic cephalgia - Wikipedia

   en.wikipedia.org/wiki/Trigeminal_autonomic_cephalgia

   Treatment for TACs varies depending on the exact type, but can include medication such as Indomethacin (in the case of chronic paroxysmal hemicrania) or acute and prophylactic therapy (in the case of cluster headache). [4]

5. Headache - Wikipedia

   en.wikipedia.org/wiki/Headache

   Abortive therapy for cluster headaches includes subcutaneous sumatriptan (injected under the skin) and triptan nasal sprays. High flow oxygen therapy also helps with relief. [11] For people with extended periods of cluster headaches, preventive therapy can be necessary. Verapamil is recommended as first line treatment. Lithium can also be useful.

6. Vagus nerve stimulation - Wikipedia

   en.wikipedia.org/wiki/Vagus_nerve_stimulation

   Vagus nerve stimulation (VNS) is a medical treatment that involves delivering electrical impulses to the vagus nerve. It is used as an add-on treatment for certain types of intractable epilepsy, cluster headaches, treatment-resistant depression and stroke rehabilitation.

7. Galcanezumab - Wikipedia

   en.wikipedia.org/wiki/Galcanezumab

   The effectiveness of galcanezumab for the treatment of episodic cluster headache was demonstrated in a clinical trial that compared it to placebo in 106 participants. [6] The trial measured the average number of cluster headaches per week for three weeks and compared the average changes from baseline in the galcanezumab and placebo groups. [6]